srinsocal:
Been in and out of BIEL a few times the previous years flipping shares; recently added some disposable funds on the chance management might actually get it right this time, though it was difficult not to sell when the PPS hit .0016 most recently. Continue to hold the latest purchase(s) pending the possibility of of enough material success to obtain a reasonable profit.
Had some success with a small pharma post FDA approval on a weight loss drug, though this is clearly a different ballgame. When it's stated that 'dilution is the business model' (which has now been altered to 'dilution is a part of the business model'), well, guess that was too tempting not to, um, respond. The other stock you mentioned was an interesting ride - real product, and a CEO who diluted the PPS to oblivion while purposefully misleading shareholders. Ugly, that. Unrestrained euphoria often leads to ludicrous statements, wild speculation, and unicorn sightings. Some rational balance might be useful. There are two very cautionary concerns here at the least: (1)the company's share structure; and (2) continued dilution. Management has missed the boat too often - which makes this a reasonable risk (perhaps), but a risk nonetheless. Even in the best of circumstance, long term gains can be tricky - the pharma previously mentioned translated FDA approval to a $10 plus increase in the PPS....helped me get a couple of kids through college - today it trades at pre-FDA approval prices; company just couldn't get the sales traction, AND the share structure was nowhere near abysmal as BIEL's at the moment.
Yes - I see possibility; no, I am not nearly as ebullient as the hard core BIELievers....
